HELIXOR P ampoules 50 mg, 8 pcs

Instructions for use of Helixor P 50 mg

Dear patient, dear patient!Please read the entire leaflet carefully as it contains important information for you.No prescription is required for this product.However, in order to achieve the best possible treatment success, Helixor® must be used correctly as directed by the doctor.

Keep the package leaflet.You may want to read these again later.Ask your doctor or pharmacist if you need further information or advice.If your symptoms worsen or do not improve, you should definitely see a doctor.If any of the side effects listed get serious or you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

1. What is Helixor® and what is it used for?

Helixor® is an anthroposophic medicine for the extended treatment of tumor diseases.In accordance with the anthroposophical knowledge of humanity and nature, Helixor® is used in adults to stimulate form and integration forces to dissolve and reintegrate growth processes that have become independent.This includes malignant tumor diseases, including those with accompanying disorders of the blood-forming organs, benign tumor diseases, defined precancerous lesions and the prevention of relapses after tumor operations.

2. What do you need to consider before using Helixor®?

Helixor® must not be used if you are hypersensitive to mistletoe preparations, suffer from an acute inflammatory or high fever illness, suffer from chronic granulomatous diseases or autoimmune diseases with severe symptoms, are under immunosuppressive treatment or suffer from hyperthyroidism with palpitations.

Particular caution is required if you are hypersensitive to other substances.In this case, particularly careful dosage must be ensured, with careful follow-up by the doctor.In the case of primary brain and spinal cord tumors or intracranial metastases with a risk of increased intracranial pressure, the preparations should only be administered according to strict indications and under close clinical control.

If Helixor® is used with other medicines, especially immune-active medicines, it should only be used after consulting a doctor.Please inform your doctor or pharmacist if you are taking or using other medicines.

Effects of Helixor® on pregnancy, the development of the unborn child, birth and on the development of the child after birth, in particular on the development of blood formation and the immune system in the unborn child/infant, have not been studied.Caution is advised when used during pregnancy and breastfeeding.

3. How to use Helixor® A/M/P?

Always use Helixor® exactly as your doctor has told you.The injection is carried out subcutaneously, if possible near the tumor or metastasis or at different locations on the intact skin.Do not inject into inflamed skin areas or radiation areas.Strict subcutaneous injection technique must be observed.

Unless otherwise prescribed, the usual dose is one subcutaneous injection 2 - 3 times weekly.Therapy begins with an introductory phase, during which the dose is gradually increased.The optimal dose must be determined individually, taking into account various reactions such as subjective well-being, temperature reaction, immunological reaction and local inflammatory reaction.

A reduction in dose may be necessary during radiation or chemotherapy.In the maintenance phase, treatment continues at the determined optimal individual dose.To avoid habituation effects, rhythmic use with alternation of doses and injection intervals as well as breaks is recommended.

After longer breaks in treatment of more than 4 weeks, the dose should initially be reduced to half as a precaution.There is no sufficient data to provide specific dosage recommendations for impaired kidney function.The dosage and injection intervals are based on individual schedules.

4. What side effects are possible?

A slight increase in body temperature, localized inflammatory reactions around the injection site and temporary slight swelling of regional lymph nodes are harmless.If there is a fever over 38 °C or major local reactions over 5 cm in diameter, the next injection should only be given after these symptoms have subsided and at a reduced strength or dose.

Local or general allergic or allergy-like reactions may occur, requiring discontinuation of the preparation and immediate medical attention.Activation of pre-existing inflammation and inflammatory irritation of superficial veins in the injection area are possible.The occurrence of chronic granulomatous inflammation, autoimmune diseases and symptoms of increased intracranial pressure in brain tumors/metastases have also been reported.

Reporting side effects: If you notice any side effects, contact your doctor or pharmacist.You can also report side effects directly via the Federal Institute for Drugs and Medical Devices.

5. How to store Helixor®?

Keep medicines out of the reach of children.You must not use the medicine after the expiry date stated on each ampoule and box.Store the ampoules in the original packaging to protect the contents from light.Helixor® 0.01 mg - 0.1 mg should be stored in the refrigerator.Helixor® 1 mg - 100 mg must not be stored above 30 °C.

6. Contents of the pack and other information

What 1 ml injection solution (1 ampoule) Helixor® contains: Active ingredient: Extract from fresh pine mistletoe herb/apple mistletoe herb/pine mistletoe herb (plant to extract = 1:20) x mg.Extracting agent: water for injections, sodium chloride (99.91: 0.09).

What 2 ml injection solution (1 ampoule) Helixor® A/M/P 100 mg contains: Active ingredient: Extract from fresh pine mistletoe/apple tree mistletoe/pine mistletoe (plant to extract = 1:20) 2,012 mg.Extracting agent: water for injections, sodium chloride (99.91: 0.09).

The strength in mg indicates the amount of fresh plant material used to produce 1 ampoule of Helixor® A/M/P.The other ingredients are table salt, sodium hydroxide and, for Helixor® 0.01 mg to 30 mg, additional water for injection purposes.

Helixor® is available in the following packs: original packs (OP) with 8 ampoules of the same concentration (0.01-100 mg), bulk packs (GP) with 50 ampoules of the same concentration (1-100 mg) and serial packs (SE) with 7 ampoules in increasing concentrations.

Pharmaceutical entrepreneur and manufacturer: Helixorheil GmbH & Co. KG, Fischermühle 1, 72348 Rosenfeld.

Helixor® P 50 mg

Active ingredient: Extract from fresh pine mistletoe extract (1:20) Viscum album ssp.austriacum;Extractants: Water for injections, sodium chloride (99.91:0.09).

Areas of application:

According to the anthroposophical knowledge of humanity and nature.These include (in adults): malignant and benign tumor diseases, malignant diseases of the hematopoietic organs, defined precancerous lesions and recurrence prevention after tumor operations.

Composition:

1 Ampoule contains: aqueous extract (1:20) from fresh pine mistletoe, equivalent to 50 mg of fresh plant.Other ingredients: sodium chloride, sodium hydroxide, water for injections.

Indication:

Areas of application according to the anthroposophical knowledge of man and nature.These include: In adults: stimulation of form and integration forces to dissolve and reintegrate independent growth processes, e.g.E.g.: in malignant tumor diseases with accompanying disorders of the blood-forming organs, in benign tumor diseases, in defined precancerous lesions and for recurrence prevention after tumor operations.

Notes

For information about risks and side effects, read the package leaflet and ask your doctor or pharmacist.Helixor P ampoules 50 mg (pack size: 8 pieces) require a pharmacy and can be purchased from your mail-order pharmacy.

Manufacturer: HELIXOR heil GmbH, Fischermühle 1, 72348 Rosenfeld.